HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Larbig Selected Research

Linagliptin

10/2014The dipeptidyl peptidase-4 inhibitor linagliptin lowers postprandial glucose and improves measures of β-cell function in type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Larbig Research Topics

Disease

3Type 2 Diabetes Mellitus (MODY)
10/2014 - 02/2010
2Seasonal Allergic Rhinitis (Hay Fever)
07/2010 - 03/2005
1Weight Gain
02/2010
1Cystic Fibrosis (Mucoviscidosis)
01/2003

Drug/Important Bio-Agent (IBA)

2AllergensIBA
07/2010 - 03/2005
2Insulin Glargine (Lantus)FDA Link
05/2010 - 02/2010
2Insulin (Novolin)FDA Link
05/2010 - 02/2010
2Metformin (Glucophage)FDA LinkGeneric
05/2010 - 02/2010
1Glucose (Dextrose)FDA LinkGeneric
10/2014
1LinagliptinIBA
10/2014
1ProinsulinIBA
05/2010
1Isophane Insulin (NPH Insulin)FDA Link
05/2010
1Nasal SpraysIBA
03/2005
1SuspensionsIBA
03/2005
1Loteprednol Etabonate (Alrex)FDA Link
03/2005
1Messenger RNA (mRNA)IBA
01/2003